Is there increasing evidence that the risks of rhAPC may outweigh its benefits?
Plataki
Maria
M
Vaporidi
Katerina
K
Georgopoulos
Dimitris
D
D000890:Anti-Infective Agents; D000075202:Contraindications; D019317:Evidence-Based Medicine; D006801:Humans; D011486:Protein C; D011994:Recombinant Proteins; D018570:Risk Assessment; D018805:Sepsis / Q000188:drug therapy*
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated